Evidence map›Paper›PMID 35641096›Full record

ArticleInternational immunology2022

Epidermal clearance of Candida albicans is mediated by IL-17 but independent of fungal innate immune receptors.

Mari T Iwasawa, Hideaki Miyachi, Seiichiro Wakabayashi, Takashi Sugihira, Reika Aoyama, Seitaro Nakagawa, Yuki Katayama, Mitsutoshi Yoneyama, Hiromitsu Hara, Yoichiro Iwakura and 8 more

Open access · hybridAbstract read
In one paragraph

Article in International immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Microbiology and molecular biology reviews : MMBR · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Mari T IwasawaDepartment of Dermatology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8670, Japan.
Hideaki MiyachiDepartment of Dermatology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8670, Japan.ORCID 0000-0003-2549-6690
Seiichiro WakabayashiDepartment of Dermatology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8670, Japan.
Takashi SugihiraDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Suita-shi, Osaka 565-0871, Japan.
Reika AoyamaDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Suita-shi, Osaka 565-0871, Japan.
Seitaro NakagawaDepartment of Dermatology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8670, Japan.
Yuki KatayamaDepartment of Dermatology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8670, Japan.
Mitsutoshi YoneyamaDivision of Molecular Immunology, Medical Mycology Research Center, Chiba University , Chiba-shi, Chiba 260-8673, Japan.
Hiromitsu HaraDepartment of Immunology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima-shi, Kagoshima 890-8544, Japan.
Yoichiro IwakuraDivision of Molecular Immunology, Medical Mycology Research Center, Chiba University , Chiba-shi, Chiba 260-8673, Japan.
Masanori MatsumotoDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Naohiro InoharaDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Hanako Koguchi-YoshiokaDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Suita-shi, Osaka 565-0871, Japan.
Manabu FujimotoDepartment of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Suita-shi, Osaka 565-0871, Japan.ORCID 0000-0002-3062-4872
Gabriel NúñezDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Hiroyuki MatsueDepartment of Dermatology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8670, Japan.
Yuumi NakamuraDepartment of Dermatology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8670, Japan.ORCID 0000-0001-6256-8302
Shinobu SaijoDivision of Molecular Immunology, Medical Mycology Research Center, Chiba University , Chiba-shi, Chiba 260-8673, Japan.
Chiba University · JPThe University of Osaka · JPUniversity of Michigan · USKagoshima University · JP

Funding

Understanding the role of S. aureus agr virulence in atopic dermatitisK01AR078931 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Masanori Matsumoto · 2022 to 2026
$454k
NIAMS NIH HHS K01 AR078931
6 · The paper itself

Abstract

IL-17 plays important roles in host defense against Candida albicans at barrier surfaces and during invasive infection. However, the role of IL-17 in host defense after colonization of the epidermis, a main site of C. albicans infection, remains poorly understood. Using a murine model of epicutaneous candidiasis without skin abrasion, we found that skin inflammation triggered by epidermal C. albicans colonization was self-limiting with fungal clearance completed by day 7 after inoculation in wild-type mice or animals deficient in IL-17A or IL-17F. In contrast, marked neutrophilic inflammation in the epidermis and impaired fungal clearance were observed in mice lacking both IL-17A and IL-17F. Clearance of C. albicans was independent of Dectin-1, Dectin-2, CARD9 (caspase-recruitment domain family, member 9), TLR2 (Toll-like receptor 2) and MyD88 in the epidermal colonization model. We found that group 3 innate lymphoid cells (ILC3s) and γδT cells were the major IL-17 producers in the epicutaneous candidiasis model. Analyses of Rag2-/- mice and Rag2-/-Il2rg-/- mice revealed that production of IL-17A and IL-17F by ILC3s was sufficient for C. albicans clearance. Finally, we found that depletion of neutrophils impaired C. albicans clearance in the epidermal colonization model. Taken together, these findings indicate a critical and redundant function of IL-17A and IL-17F produced by ILC3s in host defense against C. albicans in the epidermis. The results also suggest that epidermal C. albicans clearance is independent of innate immune receptors or that these receptors act redundantly in fungal recognition and clearance.

Indexed as

Candida albicansCandidiasisAnimalsCARD Signaling Adaptor ProteinsEpidermisImmunity, InnateInflammationInterleukin-17LymphocytesMiceMice, Inbred C57BLMice, KnockoutCard9 protein, mouseCARD Signaling Adaptor ProteinsIl17a protein, mouseInterleukin-17epicutaneous candidiasisinnate immune receptors

Identifiers

PMID35641096
PMCPMC9317997
OpenAlexW4281711961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.